Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

United States117th CongressHRES-484House of Representatives
Updated: Nov 1, 2022

Summary

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on the Judiciary.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

    House of Representatives

All available records shown.